Literature DB >> 1644659

p53 gene mutations in esophageal cancer detected by polymerase chain reaction single-strand conformation polymorphism analysis.

G Tamura1, C Maesawa, Y Suzuki, R Satodate, K Ishida, K Saito.   

Abstract

Mutations of the p53 gene play an important role in the development of common human malignancies. We investigated mutations of this gene in 26 surgical specimens of esophageal cancer using the polymerase chain reaction single-strand conformation polymorphism (PCR-SSCP) analysis. The results were correlated with histological findings, DNA ploidy and the short-term relapse of the disease. PCR-SSCP analysis detected mutations of the p53 gene in 10 tumors (38%), eight in exons 5-6 and two in exons 7-8. A higher incidence of lymph node metastasis, poorly differentiated tumor, DNA aneuploidy and short-term relapse of the disease was observed in cases with p53 gene mutations, although the findings were not statistically significant.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1644659      PMCID: PMC5918882          DOI: 10.1111/j.1349-7006.1992.tb00125.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  23 in total

1.  Allele-specific polymerase chain reaction: a method for amplification and sequence determination of a single component among a mixture of sequence variants.

Authors:  Y Suzuki; T Sekiya; K Hayashi
Journal:  Anal Biochem       Date:  1991-01       Impact factor: 3.365

2.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.

Authors:  M Orita; Y Suzuki; T Sekiya; K Hayashi
Journal:  Genomics       Date:  1989-11       Impact factor: 5.736

3.  Overexpression and mutation of p53 in epithelial ovarian cancer.

Authors:  J R Marks; A M Davidoff; B J Kerns; P A Humphrey; J C Pence; R K Dodge; D L Clarke-Pearson; J D Iglehart; R C Bast; A Berchuck
Journal:  Cancer Res       Date:  1991-06-01       Impact factor: 12.701

4.  Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.

Authors:  M Orita; H Iwahana; H Kanazawa; K Hayashi; T Sekiya
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

5.  The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17p13).

Authors:  O W McBride; D Merry; D Givol
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

6.  p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis.

Authors:  S J Baker; A C Preisinger; J M Jessup; C Paraskeva; S Markowitz; J K Willson; S Hamilton; B Vogelstein
Journal:  Cancer Res       Date:  1990-12-01       Impact factor: 12.701

7.  Mutations in the p53 gene occur in diverse human tumour types.

Authors:  J M Nigro; S J Baker; A C Preisinger; J M Jessup; R Hostetter; K Cleary; S H Bigner; N Davidson; S Baylin; P Devilee
Journal:  Nature       Date:  1989-12-07       Impact factor: 49.962

8.  Simultaneous monitoring of P53 protein and DNA content of colorectal adenocarcinomas by flow cytometry.

Authors:  Y Remvikos; P Laurent-Puig; R J Salmon; G Frelat; B Dutrillaux; G Thomas
Journal:  Int J Cancer       Date:  1990-03-15       Impact factor: 7.396

9.  Amplification of the EGF receptor and c-myc genes in human esophageal cancers.

Authors:  S H Lu; L L Hsieh; F C Luo; I B Weinstein
Journal:  Int J Cancer       Date:  1988-10-15       Impact factor: 7.396

10.  Increased expression of mutant forms of p53 oncogene in primary lung cancer.

Authors:  R Iggo; K Gatter; J Bartek; D Lane; A L Harris
Journal:  Lancet       Date:  1990-03-24       Impact factor: 79.321

View more
  6 in total

Review 1.  International cancer seminars: a focus on esophageal squamous cell carcinoma.

Authors:  G Murphy; V McCormack; B Abedi-Ardekani; M Arnold; M C Camargo; N A Dar; S M Dawsey; A Etemadi; R C Fitzgerald; D E Fleischer; N D Freedman; A M Goldstein; S Gopal; M Hashemian; N Hu; P L Hyland; B Kaimila; F Kamangar; R Malekzadeh; C G Mathew; D Menya; G Mulima; M M Mwachiro; A Mwasamwaja; N Pritchett; Y-L Qiao; L F Ribeiro-Pinto; M Ricciardone; J Schüz; F Sitas; P R Taylor; K Van Loon; S-M Wang; W-Q Wei; C P Wild; C Wu; C C Abnet; S J Chanock; P Brennan
Journal:  Ann Oncol       Date:  2017-09-01       Impact factor: 32.976

2.  Expression of p53 protein related to human papillomavirus and DNA ploidy in superficial esophageal carcinoma.

Authors:  T Nakamura; H Ide; R Eguchi; K Hayashi; F Hanyu; K Nagasako; M Yukawa; K Asaka; T Fujimori; S Maeda
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

Review 3.  Multimodality treatment of cancer arising from Barrett's epithelium.

Authors:  J A Roth
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

Review 4.  Modulation of oncogene and tumor-suppressor gene expression: a novel strategy for cancer prevention and treatment.

Authors:  J A Roth
Journal:  Ann Surg Oncol       Date:  1994-01       Impact factor: 5.344

5.  Significance of p53 expression as a prognostic factor in oesophageal squamous cell carcinoma.

Authors:  K Shimaya; H Shiozaki; M Inoue; H Tahara; T Monden; T Shimano; T Mori
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

6.  Sensitive detection of p53 gene mutations in esophageal endoscopic biopsy specimens by cell sorting combined with polymerase chain reaction single-strand conformation polymorphism analysis.

Authors:  C Maesawa; G Tamura; Y Suzuki; K Ishida; K Saito; R Satodate
Journal:  Jpn J Cancer Res       Date:  1992-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.